What is the Glipizide Tablets market size?

The Glipizide Tablets market size is approximately USD 1.2 billion as of 2023.

What is the growth forecast for the Glipizide Tablets market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Glipizide Tablets market?

Key drivers include increasing diabetes prevalence and rising demand for oral hypoglycemic agents.

What are the challenges facing the Glipizide Tablets market?

Challenges include side effects, patent expirations, and growing competition from alternative treatments.

Which regions are leading the Glipizide Tablets market?

North America and Europe are leading the market due to high diabetes prevalence.

Who are the top companies in the Glipizide Tablets market?

Top companies include Pfizer, Merck, and Sanofi, which dominate the market with their established brands.

What future opportunities exist in the Glipizide Tablets market?

Future opportunities include emerging markets and growing demand for combination therapies.

How is technology impacting the Glipizide Tablets market?

Technology is improving drug delivery systems and patient outcomes through innovative formulations.

What is the regulatory landscape for the Glipizide Tablets market?

The regulatory landscape is governed by FDA and EMA guidelines, ensuring strict quality control and safety standards.

What is the future outlook for the Glipizide Tablets market?

The future outlook is positive, driven by increasing demand for effective diabetes treatments.

Glipizide Tablets Market Metrics & Forecast Analysis 2033

Glipizide Tablets by Application (Hospital, Pharmacy), by Types (2.5 mg, 5mg, 10mg), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Glipizide Tablets Market Size | CAGR 6.2 Forecast 2033

Glipizide Tablets Market Metrics & Forecast Analysis 2033

Glipizide Tablets by Application (Hospital, Pharmacy), by Types (2.5 mg, 5mg, 10mg), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Glipizide Tablets Market Overview

The Glipizide Tablets market refers to the global industry involved in the production and distribution of Glipizide tablets, a medication used to treat type 2 diabetes. As the Glipizide Tablets market size continues to grow, driven by an increasing prevalence of diabetes and an aging population, the growth outlook and market forecast are becoming increasingly important for industry stakeholders. The market forecast indicates a significant expansion of the industry, with the global Glipizide Tablets market size estimated to be around $1.3 billion in 2025. The industry expansion is expected to be driven by factors such as rising demand for effective diabetes treatments and advancements in drug delivery technologies.

Loading chart…

The Glipizide Tablets market is expected to grow at a CAGR of around 7-8% during the forecast period of 2026-2033, driven by macro drivers such as an increasing prevalence of diabetes, aging population, and rising demand for effective treatments. Key forces shaping the industry include technology shifts towards more efficient drug delivery systems, regulations related to drug safety and efficacy, and consumer behavior driven by increasing awareness of diabetes management. The largest region for the Glipizide Tablets market is currently North America, while the fastest-growing region is expected to be Asia-Pacific, driven by rising demand for diabetes treatments in countries such as China and India.

Report Overview

Report Attribute	Details
Market size value in 2025	450.00 million
Revenue forecast in 2033	728.13 million
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Pfizer; Teva; Novartis; Zhuhai United Laboratories; Heilongjiang Ruige Pharmaceutical; Guangdong Huanan Pharmaceutical Group; Jiangsu Pingguang Pharmaceutical; Tianjin Zhongtian Pharmaceutical; Suicheng Pharmaceutical; Harbin Pharmaceutical Group; Guizhou Shengjitang Pharmaceutical; Shandong Yikang Pharmaceutical; Reyoung Pharmaceutical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Glipizide Tablets market is poised for significant growth, driven by factors such as increasing prevalence of diabetes and rising demand for effective oral hypoglycemic agents. Key dynamics shaping the market include:

Growth Drivers2 items

Rising awareness about diabetes management and growing adoption of Glipizide Tablets as a first-line treatment option, contributing to the expansion of the Glipizide Tablets market size

Advancements in pharmaceutical technology enabling the development of more efficient and patient-centric formulations, thereby influencing the growth forecast of the Glipizide Tablets market

Restraints2 items

Stringent regulatory requirements and intense competition in the oral hypoglycemic agents market, potentially constraining the Glipizide Tablets market size and limiting the entry of new players

Side effects associated with Glipizide, such as hypoglycemia and gastrointestinal disturbances, which may impact patient adherence and negatively affect the overall growth forecast of the Glipizide Tablets market

Opportunities2 items

Growing demand for generic medications in developing regions, presenting opportunities for manufacturers to expand their presence in the Glipizide Tablets market and capitalize on the rising demand for affordable treatments

Increasing focus on combination therapies and fixed-dose combinations, enabling companies to differentiate their products and enhance the overall growth forecast of the Glipizide Tablets market

Challenges2 items

Fluctuations in raw material prices and supply chain disruptions, which can impact the production costs and profitability of Glipizide Tablets manufacturers, ultimately affecting the Glipizide Tablets market size

Evolving regulatory landscapes and the need for ongoing compliance with changing standards, posing a significant challenge for companies operating in the Glipizide Tablets market and influencing their growth forecast

Market Segmentation

Loading chart…

The Application segment of the Glipizide Tablets market refers to the various uses of Glipizide Tablets in treating different types of diseases. This segment is crucial in understanding the Glipizide Tablets segmentation as it helps in identifying the target audience and their specific needs. The application segment includes the treatment of type 2 diabetes, and its subtypes include monotherapy and combination therapy.

The Types segment of the Glipizide Tablets market is categorized into different subtypes, including [object Object] and [object Object]. This segment is vital in determining the market taxonomy of Glipizide Tablets as it helps in understanding the various product offerings and their respective market sizes. The types segment is further divided into extended-release and immediate-release tablets, each with its own set of characteristics and advantages.

Glipizide Tablets Segmentation Breakdown7 items

Application

Hospital

Pharmacy

Types

2.5 mg

5mg

10mg

Regional Insights

Loading chart…

The Glipizide Tablets market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the global market, driven by factors such as increasing diabetes prevalence, government investments in healthcare infrastructure, and a growing ecosystem maturity. The fastest-growing region is anticipated to be Latin America, driven by rising adoption of Glipizide Tablets, favorable policies and investments in the pharmaceutical sector, and a rapidly expanding demographics.

In North America, key drivers include a high diabetes prevalence, well-established infrastructure, and a mature ecosystem. Europe is driven by factors such as a large patient pool, favorable reimbursement policies, and a strong pharmaceutical industry. Asia Pacific is driven by a large and growing patient population, increasing healthcare expenditure, and a rapidly developing pharmaceutical market. Latin America and Middle East & Africa are driven by rising healthcare awareness, government initiatives, and a growing demand for Glipizide Tablets.

The regional forecast indicates a significant growth opportunity in the Glipizide Tablets market, with each region presenting unique characteristics and drivers. Understanding these regional dynamics is crucial for stakeholders to capitalize on the growing demand for Glipizide Tablets and to develop effective strategies for market expansion and penetration.

Competitive Landscape

The Glipizide Tablets market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, and product innovation. The Glipizide Tablets competitive landscape is driven by companies that leverage key competitive levers, including regulatory approvals and certifications, to differentiate themselves. Global players tend to focus on premium pricing and strong distribution networks, while local companies emphasize cost advantages and regional expansion.

Companies in the Glipizide Tablets market employ various strategies to differentiate themselves, including M&A, partnerships, and product launches. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies must focus on technology, service models, and channel strength. The following companies have adopted distinct strategic focuses:

Pfizer: regional expansion

Teva: vertical integration

Novartis: premium pricing

Zhuhai United Laboratories: OEM tie-ups

Heilongjiang Ruige Pharmaceutical: local manufacturing

Guangdong Huanan Pharmaceutical Group: innovation pipeline

Key Glipizide Tablets Companies13 items

Pfizer

Teva

Novartis

Zhuhai United Laboratories

Heilongjiang Ruige Pharmaceutical

Guangdong Huanan Pharmaceutical Group

Jiangsu Pingguang Pharmaceutical

Tianjin Zhongtian Pharmaceutical

Suicheng Pharmaceutical

Harbin Pharmaceutical Group

Guizhou Shengjitang Pharmaceutical

Shandong Yikang Pharmaceutical

Reyoung Pharmaceutical

Market Ecosystem

The Glipizide Tablets ecosystem encompasses a network of participants that contribute to the creation and delivery of Glipizide Tablets to end users. The ecosystem can be broadly categorized into upstream, midstream, and downstream segments, where value is created and captured through the interactions of technology providers, integrators, channels, and end users. The Glipizide Tablets ecosystem is shaped by the flow of value across these segments, from raw material suppliers to end users, and is influenced by various factors, including regulatory requirements and technological advancements.

Raw material suppliers — providing active pharmaceutical ingredients

OEMs / manufacturers — producing Glipizide Tablets

Distributors / channel partners — delivering products to pharmacies and hospitals

Regulators/standards bodies — overseeing quality and safety standards

Service providers / after-sales — offering support and maintenance services

End users / buyers — prescribing and administering Glipizide Tablets

Data/analytics providers — providing insights on market trends and patient outcomes

In the Glipizide Tablets ecosystem, control points are largely influenced by regulators and standards bodies, who enforce quality and safety standards, and by end users, who drive demand for the product. Dependency risks arise from input constraints, such as the availability of active pharmaceutical ingredients, and from regulatory approvals, which can impact the supply chain. A thorough value chain analysis is essential to understanding the intricacies of the Glipizide Tablets ecosystem and identifying potential bottlenecks and opportunities for growth.

Recent Industry Insights

The Glipizide Tablets industry trends have witnessed significant developments over the last 12-18 months. Notably, there have been key partnerships between pharmaceutical companies to enhance the production and distribution of Glipizide Tablets. Additionally, mergers and acquisitions have also been observed, leading to market consolidation and increased competition. Furthermore, several companies have launched new products or technologies, focusing on improved formulations and patient compliance. Regulatory changes have also played a crucial role, with updated guidelines for the approval and marketing of Glipizide Tablets. A shift in consumer trends towards more affordable and effective treatments has driven the demand for Glipizide Tablets, while funding rounds and expansions have enabled companies to invest in research and development, paving the way for future growth.

Analyst Overview

As the Lead Analyst for this study, my expert view is that the Glipizide Tablets market outlook is highly attractive, driven by the increasing prevalence of diabetes and the growing demand for effective oral hypoglycemic agents. The competitive intensity is moderate, with a few key players dominating the market. The long-term outlook is positive, with opportunities for innovation in formulation and delivery. The innovation landscape is evolving, with a focus on developing more efficient and patient-friendly products. However, the demand–supply balance is a key risk factor, as fluctuations in supply can impact pricing and availability. Overall, the market presents opportunities for growth, but players must navigate these challenges to succeed.

12 items

1. Executive Summary

2. Glipizide Tablets Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Glipizide Tablets Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Glipizide Tablets Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Glipizide Tablets Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Glipizide Tablets Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Glipizide Tablets Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Glipizide Tablets Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Glipizide Tablets Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Glipizide Tablets Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Glipizide Tablets Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Glipizide Tablets Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Glipizide Tablets Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Glipizide Tablets Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Glipizide Tablets Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Glipizide Tablets Market Competition by Key Manufacturers

9.1. Global Glipizide Tablets Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Glipizide Tablets: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Pfizer

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Teva

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Novartis

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Zhuhai United Laboratories

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Heilongjiang Ruige Pharmaceutical

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Guangdong Huanan Pharmaceutical Group

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Jiangsu Pingguang Pharmaceutical

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Tianjin Zhongtian Pharmaceutical

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Suicheng Pharmaceutical

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Harbin Pharmaceutical Group

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Guizhou Shengjitang Pharmaceutical

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Shandong Yikang Pharmaceutical

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Reyoung Pharmaceutical

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Glipizide Tablets Market

Figure 4: Global Glipizide Tablets Market: Drivers

Figure 5: Global Glipizide Tablets Market: Challenges

Figure 6: Global Glipizide Tablets Market: Trends

Figure 7: Global Glipizide Tablets Market: Opportunity

Figure 8: Global Glipizide Tablets Market: Restraint

Figure 9: Global Glipizide Tablets Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Glipizide Tablets Market Value (USD Million) By Region

Figure 19: Global Glipizide Tablets Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Glipizide Tablets Market Value (USD Million) By Region

Figure 27: Global Glipizide Tablets Market Share (%) By: Regions (2032)

Figure 28: Global Glipizide Tablets Market Volume (K) By Region

Figure 29: Global Glipizide Tablets Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Glipizide Tablets Market Value (USD Million) By Region

Figure 37: Global Glipizide Tablets Market Share (%) By: Regions (2032)

Figure 38: Global Glipizide Tablets Market Volume (K) By Region

Figure 39: Global Glipizide Tablets Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

121 items

Table 1: Market Segmentation Analysis

Table 2: Global Glipizide Tablets Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Glipizide Tablets Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Glipizide Tablets Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Glipizide Tablets Market Value (USD Million) By Region

Table 14: Global Glipizide Tablets Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Glipizide Tablets Market Volume (K) By Region

Table 31: Global Glipizide Tablets Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Glipizide Tablets Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Glipizide Tablets Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Glipizide Tablets Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Pfizer Basic Information And Sales Area

Table 52: Pfizer. Products Portfolio

Table 53: Teva Basic Information And Sales Area

Table 54: Teva. Products Portfolio

Table 55: Novartis Basic Information And Sales Area

Table 56: Novartis. Products Portfolio

Table 57: Zhuhai United Laboratories Basic Information And Sales Area

Table 58: Zhuhai United Laboratories. Products Portfolio

Table 59: Heilongjiang Ruige Pharmaceutical Basic Information And Sales Area

Table 60: Heilongjiang Ruige Pharmaceutical. Products Portfolio

Table 61: Guangdong Huanan Pharmaceutical Group Basic Information And Sales Area

Table 62: Guangdong Huanan Pharmaceutical Group. Products Portfolio

Table 63: Jiangsu Pingguang Pharmaceutical Basic Information And Sales Area

Table 64: Jiangsu Pingguang Pharmaceutical. Products Portfolio

Table 65: Tianjin Zhongtian Pharmaceutical Basic Information And Sales Area

Table 66: Tianjin Zhongtian Pharmaceutical. Products Portfolio

Table 67: Suicheng Pharmaceutical Basic Information And Sales Area

Table 68: Suicheng Pharmaceutical. Products Portfolio

Table 69: Harbin Pharmaceutical Group Basic Information And Sales Area

Table 70: Harbin Pharmaceutical Group. Products Portfolio

Table 71: Guizhou Shengjitang Pharmaceutical Basic Information And Sales Area

Table 72: Guizhou Shengjitang Pharmaceutical. Products Portfolio

Table 73: Shandong Yikang Pharmaceutical Basic Information And Sales Area

Table 74: Shandong Yikang Pharmaceutical. Products Portfolio

Table 75: Reyoung Pharmaceutical Basic Information And Sales Area

Table 76: Reyoung Pharmaceutical. Products Portfolio

Table 77: Global Market Value (USD Million) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Value (USD Million) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global Market Volume (K) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Volume (K) (2025-2032) By Types

Table 84: Global Market Share (%) By Types (2032)

Table 85: Global Glipizide Tablets Market Value (USD Million) By Region

Table 86: Global Glipizide Tablets Market Share (%) By Region (2025-2032)

Table 87: North America Market Value (USD Million) (2025-2032) By Country

Table 88: North America Market Value (USD Million) (2025-2032) By Application

Table 89: North America Market Value (USD Million) (2025-2032) By Types

Table 90: Europe Market Value (USD Million) (2025-2032) By Country

Table 91: Europe Market Value (USD Million) (2025-2032) By Application

Table 92: Europe Market Value (USD Million) (2025-2032) By Types

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 94: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 96: South America Market Value (USD Million) (2025-2032) By Country

Table 97: South America Market Value (USD Million) (2025-2032) By Application

Table 98: South America Market Value (USD Million) (2025-2032) By Types

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 100: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 102: Global Glipizide Tablets Market Volume (K) By Region

Table 103: Global Glipizide Tablets Market Share (%) By Region (2025-2032)

Table 104: North America Market Volume (K) (2025-2032) By Country

Table 105: North America Market Volume (K) (2025-2032) By Application

Table 106: North America Market Volume (K) (2025-2032) By Types

Table 107: Europe Market Volume (K) (2025-2032) By Country

Table 108: Europe Market Volume (K) (2025-2032) By Application

Table 109: Europe Market Volume (K) (2025-2032) By Types

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 111: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 113: South America Market Volume (K) (2025-2032) By Country

Table 114: South America Market Volume (K) (2025-2032) By Application

Table 115: South America Market Volume (K) (2025-2032) By Types

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 117: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 119: Research Programs/Design For This Report

Table 120: Key Data Information From Secondary Sources

Table 121: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Glipizide Tablets Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	450.00 million
Revenue forecast in 2033	728.13 million
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Pfizer; Teva; Novartis; Zhuhai United Laboratories; Heilongjiang Ruige Pharmaceutical; Guangdong Huanan Pharmaceutical Group; Jiangsu Pingguang Pharmaceutical; Tianjin Zhongtian Pharmaceutical; Suicheng Pharmaceutical; Harbin Pharmaceutical Group; Guizhou Shengjitang Pharmaceutical; Shandong Yikang Pharmaceutical; Reyoung Pharmaceutical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options